Activity modulation of Beclin-1/class Ⅲ PI3 complex and mTOR complex 1 in Ischemia/Reperfusion induc

来源 :华中科技大学 | 被引量 : 0次 | 上传用户:syw2565
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Multiple cell signaling pathways and biological processes are involved in cerebralischemia/reperfusion (I/R)injury,among which,autophagy is a most confusmg one.Studiessuggest that autophagy is activated during ischemia and reperfusion (I/R),however theresno data to dynamically mimic autophagy level during the whole process of I/R,and its stillnot known whether autophagy functions as a guardian or plays a detrimental role in I/RinJury. Here we employed simulated I/R of N2a cells (mouse neuroblastoma cells)as an in vitromodel of I/R injury to the neurons.LC-311 level was checked by immunoblot analysis atdifferent time points of ischemia process,and different intervals of reperfusion.Resultsshowed that autophagy was gradually activated as ischemia went on,and greatly elevatedduring the process of reperfusion after 90minutes ischemia insult.I/R manipulation wasalso applied to N2a cells transfected with EGFP-LC3,punctate EGFP-LC3 was monitored,percentage of cells displaying obvious EGFP-LC3 puncta coincided with the forenamedimmunoblot results.Also,we found that autophagy was induced in hippocampus andcortex of rats underwent MCAO for 90 minutes and reperfusion for a week. Beclin-1 in cytosol,p-mTOR,p-P70 S6K were also checked in ischemia/reperfusiongroups by immunoblot analysis,results indicated that Beclin-1 in cytosol shared the samechange pattern with LC-311,while p-P70 S6K and p-mTOR showed delayed decrease afterreperfusion.Administration of 3MA,inhibitor of class Ⅲ PI3K,definitely abolishedautophagy during reperfusion,while employment of rapamycin,inhibitor of mTORC1,surprisingly weakened autophagy activation during reperfusion. Analyses of mitochondria function by relative cell viability were performed in I/R modelgroups and 3MA-treated groups,results came that autophagy inhibition by 3MA definitelyhold back the decline of mitochondria function during the process of reperfusion.
其他文献
自1971年,顺铂(顺式二氯二氨合铂)成功应用于临床癌症治疗后,具有生物功能的金属配合物作为可能的新型治疗药物,成为生物无机化学领域的研究热点。尿素酶是一种含有金属镍的金属酶,对动植物均会带来一定的消极作用。因此,利用脲酶抑制剂抑制尿素酶活性具有十分重要的意义。传统的有机化学脲酶抑制剂药物具有一定的毒副作用、抑制机理不明确等缺陷。因此,寻求高效、抑制机理明确的金属配合物型的脲酶抑制剂十分重要。哌嗪